Compare PRME & WDAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRME | WDAY |
|---|---|---|
| Founded | 2019 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 666.1M | 56.7B |
| IPO Year | 2022 | 2012 |
| Metric | PRME | WDAY |
|---|---|---|
| Price | $3.65 | $133.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 33 |
| Target Price | $7.56 | ★ $202.26 |
| AVG Volume (30 Days) | 2.6M | ★ 5.5M |
| Earning Date | 06-01-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.18 | N/A |
| EPS | N/A | ★ 2.03 |
| Revenue | $4,632,000.00 | ★ $2,143,050,000.00 |
| Revenue This Year | $15.20 | $14.04 |
| Revenue Next Year | $316.23 | $11.33 |
| P/E Ratio | ★ N/A | $66.12 |
| Revenue Growth | ★ 55.28 | 36.55 |
| 52 Week Low | $1.11 | $117.76 |
| 52 Week High | $6.94 | $276.00 |
| Indicator | PRME | WDAY |
|---|---|---|
| Relative Strength Index (RSI) | 44.99 | 34.63 |
| Support Level | $3.19 | $117.76 |
| Resistance Level | $4.66 | $150.69 |
| Average True Range (ATR) | 0.32 | 6.33 |
| MACD | -0.04 | 1.49 |
| Stochastic Oscillator | 22.26 | 46.46 |
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Workday is a software company that offers human capital management, financial management, and business planning solutions for enterprises. Known for being a cloud-only software provider, Workday was founded in 2005 and is headquartered in Pleasanton, California.